The effects of cyclic peptide [R4W4] in combination with first-line therapy on the survival of Mycobacterium avium
Our findings show that liposomal combination [R4W4] is a promising adjuvant therapy to increase <i>M. avium</i> susceptibility to known antibiotics.
Authors
- Nadia Rai (ORCID: https://orcid.org/0000-0003-4682-9888)
- Vishwanath Venketaraman (ORCID: https://orcid.org/0000-0002-2586-1160)
- Rakesh Kumar Tiwari (ORCID: https://orcid.org/0000-0003-3701-4548)
- Kayvan Sasaninia (ORCID: https://orcid.org/0000-0003-4299-3621)
- Melissa Kelley
- Arbi Abnousian
- Ira Glassman (ORCID: https://orcid.org/0000-0001-5651-6282)
- Ali Badaoui (ORCID: https://orcid.org/0009-0008-5441-3982)
Institutions
- Islamia University of Bahawalpur (PK)
- Chapman University (US)
- Pacific Northwest University of Health Sciences (US)
- Western University of Health Sciences (US)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fcimb.2025.1547376
- Citations
- 2
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute